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 2 
Abstract 1 
Follicular dendritic cells (FDCs) in lymphoid organs play an 2 
important role in the humoral immune response. However, because the 3 
isolation of FDCs is difficult due to their very small population size and 4 
fragility under mechanical and chemical stresses, the genetic and 5 
biochemical characteristics of FDCs remain unclear. Previously, we 6 
identified FDCs as ICAM-1+ cells in the CD45− non-hematopoietic cell 7 
fraction from naïve mouse spleen after cell separation by means of digestion 8 
with a combination of enzymes. In the present study, using a new 9 
combination of enzymes, we found that FDCs are highly enriched in the 10 
CD45−ICAM-1+CD21/35+ cell fraction. CD45−ICAM-1+CD21/35+ cells in the 11 
mouse spleen retained an antigen administered in vivo for more than 7 days. 12 
Moreover, CD45−ICAM-1+CD21/35+ cells isolated from the spleen of mice 13 
administered with a cognate antigen enhanced the survival and proliferation 14 
of antigen-specific B cells in vitro. Our improved protocol for the isolation of 15 
naïve FDCs will be useful for the analysis of FDCs in vitro and in vivo. 16 
 3 
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1. Introduction 1 
Follicular dendritic cells (FDCs) were identified in 1965 as 2 
antigen-retaining reticular cells in lymphoid organs (Mitchell and Abbot, 3 
1965). FDCs are non-hematopoietic antigen-presenting cells that can be 4 
distinguished from conventional dendritic cells (Chen et al., 1978a, 1978b; 5 
Turley et al., 2010). FDCs present antigen via CD21/35 to B cells and support 6 
the clonal expansion of B cells in germinal center and immunoglobulin 7 
class-switching, and for the B-cell-receptor gene to undergo somatic 8 
hypermutation (Victora and Nussenzweig, 2012). Thus, FDCs play an 9 
important role in the humoral immune response. 10 
Immunohistochemical analysis has partially revealed the 11 
phenotypic characteristics of FDCs; however, because the isolation of FDCs 12 
is difficult due to their scarcity in lymphoid organs and their fragility under 13 
mechanical and chemical stresses, the molecular and functional 14 
characteristics of FDCs remain unclear. Conventionally, FDCs are isolated 15 
as FDC-M1+ cells by using magnetic cell-separation technology after 16 
 5 
whole-body irradiation and enzymatic digestion (Sukumar et al., 2006). 1 
However, the molecular marker FDC-M1 is detected not only in FDCs but 2 
also in cells located in the marginal sinus and tingible body macrophages 3 
(Kranich et al., 2008; Krautler et al., 2012). In addition, whole-body 4 
irradiation induces systemic inflammation through the release of 5 
damage-associated molecular pattern molecules from damaged tissue 6 
(Schaue et al., 2015), which might cause unexpected FDC activation. Thus, 7 
FDCs isolated after whole-body irradiation are not suitable for the biological 8 
study of naïve FDCs. Although previous reports described FDCs isolated 9 
from lymph nodes of naïve mice without irradiation (Fasnacht et al., 2014; 10 
Jarjour et al., 2014; Tamburini et al., 2014), phenotypical and functional 11 
characteristics of those FDCs were unclear. 12 
Previously, we reported a unique method to isolate FDCs from the 13 
CD45−ICAM-1+ cell population in the lymphoid organs of non-irradiated 14 
naïve mice by means of flow cytometry (Usui et al., 2012). In the present 15 
study, we used a new combination of enzymes for cell separation to subdivide 16 
 6 
the CD45−ICAM-1+ cell population into CD21/35+ and CD21/35− cell 1 
populations. Here we describe this improved method for producing highly 2 
enriched preparations of FDCs. 3 
4 
 7 
2. Materials and methods 1 
 2 
2.1. Mice 3 
C57BL/6J mice were purchased from Clea Japan Inc. (Tokyo, Japan) and 4 
maintained under specific pathogen-free (SPF) conditions. Quasi-monoclonal 5 
(QM) mice, in which transgenic B cell receptor specifically reacts with 6 
4-hydroxy-3-nitrophenylacetyl (NP) antigen, are homozygous for the Vht 7 
gene (Vht/Vht, Jκ−/Jκ−, λ+/λ+). All experiments were performed according to 8 
the guidelines of the Animal Ethics Committee of the University of Tsukuba 9 
Animal Research Center. 10 
 11 
2.2. Antibodies and reagents 12 
Fluorescein isothiocyanate (FITC)-conjugated anti-mouse CD31 (clone, 390), 13 
R-phycoerythrin (PE)-conjugated anti-mouse ICAM-1 (3E2), anti-mouse 14 
CD45.2 (104), Alexa647-conjugated anti-mouse CD31 (390), allophycocyanin 15 
(APC)-conjugated anti-mouse CD19 (1D3), anti-mouse CD45R/B220 16 
 8 
(RA3-6B2), Horizon V450-conjugated anti-mouse CD45.2 (104), and 1 
biotin-conjugated anti-mouse CD45 (30-F11) monoclonal antibodies (mAbs) 2 
were purchased from BD Biosciences (San Jose, CA, USA). Purified 3 
anti-mouse CD16/32 (2.4G2), and PECy7-conjugated rat IgG2a isotype 4 
control (2A3) mAbs were purchased from Tonbo Biosciences (San Diego, CA, 5 
USA). PECy7-conjugated anti-mouse CD21/35 (7G6), biotin-conjugated 6 
anti-mouse CD45R/B220 (RA3-6B2), and biotin-conjugated anti-mouse 7 
Ter119 (Ter-119) mAbs were purchased from BioLegend (San Diego, CA, 8 
USA). eFluor660-conjugated anti-mouse podoplanin (PDPN) (eBio8.1.1) mAb 9 
was purchased from eBioscience (San Diego, CA, USA). Biotin-conjugated 10 
anti-FDC-M2 (FDC-M2) mAb was purchased from ImmunoKontact 11 
(Abingdon, UK). NP-Ficoll and 2, 4, 6-trinitrophenyl (TNP)-Ficoll were 12 
purchased from Biosearch Technologies (Novato, CA, USA) and TNP-Ficoll 13 
was labeled to produce FITC-TNP-Ficoll by using a FluoReporter FITC 14 
Labeling Kit (Thermo Fisher Scientific, MA, USA), in accordance with the 15 
manufacturer’s instructions. 16 
 9 
 1 
2.3. Isolation of stromal cell subsets 2 
Stromal cells were isolated by using a method reported previously with 3 
modifications (Usui et al., 2012). Spleen from naïve mice was minced into a 4 
homogenous paste with a scalpel on a dish plate and then treated with 2 ml 5 
of an enzyme cocktail containing 1 mg/mL collagenase D (Roche, 6 
Indianapolis, IN, USA), 100 μg/mL DNase I (Sigma, St. Louis, MO, USA) 7 
and 0.6 U/mL Dispase (Roche, Indianapolis, IN, USA) in complete Dulbecco’s 8 
modified Eagle’s medium (cDMEM) containing 2% fetal bovine serum (FBS). 9 
After incubation in a 24-well plate for 30 min at 37°C in a humidified 10 
incubator, cell suspensions were passed through a 100 µm nylon cell strainer 11 
(Corning, NY, USA) and cells were resuspended in cDMEM containing 10% 12 
FBS and 5 mM ethylenediaminetetraacetic acid (EDTA). For lysis of red 13 
blood cells, cells were incubated with 1 ml of ammonium-chloride-potassium 14 
lysing buffer for one spleen for 2 min, washed once with cDMEM, and 15 
subsequently once with the washing buffer (PBS containing 2 % FBS and 5 16 
 10 
mM EDTA). Cells were resuspended in the washing buffer at 109/ml and 1 
incubated with 2.5 µg purified anti-mouse CD16/32 mAb for 108 cells for 20 2 
min on ice. Cells were then stained with a biotin-conjugated anti-mouse 3 
mAbs cocktail containing anti-CD45 (2.5 µg), anti-B220 (1 µg), and 4 
anti-anti-Ter119 (1 µg) for 108 cells for 30 min on ice. Unlabeled cells were 5 
then negatively selected by magnetic separation with BD IMag SAv particles 6 
(BD Pharmingen, San Diego, CA) in accordance with the manufacturer’s 7 
instructions. Finally, cells were stained with V450-conjugated anti-CD45.2, 8 
FITC or Alexa647-conjugated anti-CD31, eFlour660-conjugated anti-PDPN, 9 
PE-conjugated anti-ICAM-1, and PECy7-conjugated anti-CD21/35 mAbs for 10 
30 min on ice, washed with the washing buffer, passed through a 100 11 
µm-nylon cell strainer, and analyzed by flow cytometry (FACSAria, BD 12 
Biosciences). Doublet and dead cells were gated out on the basis of 13 
forward-scatter A (FSC) and FSC H properties and PI staining, respectively. 14 
CD45−ICAM-1+CD21/35+ cells and other stromal cells were sorted by using a 15 
flow cytometry (FACSAria) (100 µm-nozzle; 20 psi). For evaluation of B cell 16 
 11 
contamination in CD45−ICAM-1+CD21/35+ fraction, anti-B220 mAb was 1 
excluded from antibody mixture for negative selection of lineage cells. For 2 
the analyses of the FDC-M2 expression on CD45−ICAM-1+CD21/35+ cells, the 3 
stromal cells were enriched with BD IMag PE particles (BD Pharmingen, 4 
San Diego, CA), instead of BD IMag SAv particles, after staining with 5 
PE-conjugated anti-mouse CD45.2 mAb. 6 
 7 
2.4. Antigen retention analysis 8 
C57BL/6J mice were immunized intravenously with 50 µg FITC-TNP-Ficoll 9 
or phosphate-buffered saline as control. Seven days later, retention of the 10 
FITC-conjugated antigen by stromal cell subsets was analyzed by means of 11 
flow cytometry. 12 
 13 
2.5. Ex vivo antigen presentation to cognate B cells 14 
Naïve QM and WT B cells were purified from naïve mouse spleen by using 15 
anti-B220 particles-DM (BD Pharmingen), in accordance with the 16 
 12 
manufacturer’s instructions, and then labeled with 500 nM 1 
carboxyfluorescein diacetate succinimidyl ester (CFSE). To assess B-cell 2 
proliferation, CFSE-labeled B cells (5 × 103 cells) were co-cultured in 3 
cDMEM medium containing 10% FBS in 96-well round-bottom plates with 4 
purified CD45−ICAM-1+ cells (500 cells) or CD45−ICAM-1+CD21/35+ cells 5 
(500 cells) cells isolated from mice given 50 μg NP-Ficoll intravenously seven 6 
days previously. Three days later, the cells were harvested and stained with 7 
APC-conjugated anti-CD19 monoclonal antibodies. The ratio of PI− cells in 8 
the CD19+ gate was used as an index of B-cell survival. The proliferation of 9 
PI−CD19+ cells was analyzed by means of the CFSE dilution assay. 10 
 11 
2.6. Quantitative polymerase chain reaction 12 
Total RNA was isolated by using Isogen reagent (Nippon Gene, Tokyo, 13 
Japan). For reverse transcription, we used a high-capacity complementary 14 
DNA reverse-transcription kit (Applied Biosystems, Carlsbad, CA, USA). 15 
Real-time polymerase chain reaction (PCR) analysis of Mfge8, Cxcl13, 16 
 13 
Fcgr2b, Cr2, Icam1, Vcam1, Fcamr, Stab2, Ccl19, and Pdgfrb was performed 1 
by using an ABI 7500 sequence detector (Applied Biosystems), Power SYBR 2 
Green PCR master mix (Applied Biosystems), and the appropriate primers. 3 
The Actb expression level was measured as the internal control to normalize 4 
the data. The primer sequences for the target genes were as follows: Mfge8: 5 
forward, 5’-ATA TGG GTT TCA TGG GCT TG-3’, reverse, 5’-GAG GCT GTA 6 
AGC CAC CTT GA-3’; Cxcl13: forward, 5’-CAT AGA TCG GAT TCA AGT 7 
TAC GCC-3’, reverse, 5’-TCT TGG TCC AGA TCA CAA CTT CA-3’; Fcgr2b: 8 
forward, 5’-TGC TGT CGC AGC CAT TGT TA-3’, reverse, 5’-TGT TGG CTC 9 
CAG TCC AGA TG-3’; Cr2: forward, 5’-AAT TGC AAA TGG TGG TCA CA-3’, 10 
reverse, 5’-GAT CGG GGC AAT GAG TTA GA-3’; Icam1: forward, 5’-TTG 11 
AGA ACT GTG GCA CCG TG-3’, reverse, 5’-CAG CTC CAC ACT CTC CGG 12 
AA-3’; Vcam1: forward, 5’-GTG ACC TGT CTG CAA AGG AC-3’, reverse, 13 
5’-AAA GGG ATA CAC ATT AGG GAC TG-3’; Fcamr: forward, 5’-CCC AGC 14 
CTG AGA ACG AGA TG-3’, reverse, 5’-AGA GAT GGG TCC TGA ACT 15 
GAG-3’; Stab2: forward, 5’-TCA AGA CGG AGT GCC AGT C-3’, reverse, 16 
 14 
5’-GCA ATC TCG AAC CCC GAC A-3’; Ccl19: forward, 5’-TTC ACG CCA 1 
CAG GAG GAC ATC T-3’, reverse, 5’-CCA CAC TCA CAT CGA CTC TCT 2 
AGG C-3’; Pdgfrb: forward, 5’-TCA AGC TGC AGG TCA ATG TC-3’, reverse, 3 
5’-CCA TTG GCA GGG TGA CTC-3’; Actb: forward, 5’-ACT GTC GAG TCG 4 
CGT CCA-3’, reverse, 5’-GCA GCG ATA TCG TCA TCC AT-3’. The thermal 5 
cycling conditions comprised an initial denaturation step at 95˚C for 10 min, 6 
followed by 40 cycles at 95˚C for 15 s and 60˚C for 1 min. The mRNA level 7 
was determined relative to that in CD45−ICAM-1+ cells. 8 
 9 
2.5. Statistical analysis 10 
Statistical analysis was performed by using the ANOVA followed by the 11 
post-hoc Tukey-Kramer test in the GraphPad Prism 5 software (GraphPad 12 
Software, Inc., San Diego, CA, USA). 13 
14 
 15 
3. Results and Discussion 1 
3.1. Isolation of CD45−ICAM-1+CD21/35+ cells from the spleen of naïve mice 2 
We found that by using an improved combination of enzymes for cell 3 
separation the CD45−ICAM-1+ cell population could be further divided into 4 
populations of CD21/35+ and CD21/35− cells (Fig. 1A). In our previous report, 5 
we used a high concentration of collagenase D (33.3 mg/mL) (Usui et al., 6 
2012); however, this caused downregulation of CD21/35 expression on the 7 
cell surface (Supplementary Fig 1). In the present study, we found that 8 
digestion with a low concentration of collagenase D (1 mg/mL) did not affect 9 
CD21/35 expression (Supplementary Fig 1) and that the addition of dispase 10 
increased the yield of CD45−ICAM-1+CD21/35+ cells (Table 1). 11 
Flow cytometric analysis showed that CD45−ICAM-1+CD21/35+ cells 12 
did not express the cell markers CD31 or PDPN, suggesting that blood 13 
endothelial cells (BECs, CD45−ICAM-1+CD31+) and fibroblastic reticular 14 
cells (FRCs, CD45−ICAM-1+PDPN+) were not contaminated in the 15 
CD45−ICAM-1+CD21/35+ cell fraction (Fig. 1A). In contrast to a previous 16 
 16 
report describing that CD35+ FDCs can be divided into PDPN+ or PDPN− 1 
population in lymph nodes (Link et al., 2007), we found that splenic 2 
CD45−ICAM-1+CD21/35+ cells isolated with our method did not express 3 
PDPN (Fig. 1A). Previous reports have suggested that the developmental 4 
mechanisms of FDCs are different between lymph nodes and spleen 5 
(Castagnaro et al., 2013; Jarjour et al., 2014; Krautler et al., 2012); therefore, 6 
FDCs might show some different phenotypes between the lymph nodes and 7 
spleen. We also confirmed that CD45−ICAM-1+CD21/35+ cells did not contain 8 
B220+ cells, indicating that B cells were not contaminated in this fraction 9 
(Fig. 1B). Taken together, these data suggest that the isolated 10 
CD45−ICAM-1+CD21/35+ cells are highly enriched FDCs. 11 
FDC-M2 is an well known FDC marker in immunohistochemical 12 
analysis. Indeed, flow cytometric analysis showed that most CD45 −13 
ICAM-1+CD21/35+ cells expressed FDC-M2 (Fig. 1C). However, FDC-M2 was 14 
also significantly detected on CD45−ICAM-1+CD31+ BECs, which is over 15 
95 % population in the CD45−ICAM-1+ fraction (Fig. 1C), indicating that the 16 
 17 
major FDC-M2+ population is BECs rather than FDCs.  1 
 2 
3.2. FDC marker gene expression in CD45−ICAM-1+CD21/35+ cells 3 
Immunohistochemical analysis has revealed that within the stromal 4 
cell fraction FDCs are characterized by the expression FDC-M1 (Mfge8), 5 
FcγRIIB (Fcgr2b), CXCL13 (Cxcl13), CD21/35 (Cr2), ICAM-1 (Icam1), 6 
VCAM-1 (Vcam1), and Fcα/µR (Fcamr) (Allen and Cyster, 2008; Honda et al., 7 
2009). To examine whether FDC purity was increased in the 8 
CD45−ICAM-1+CD21/35+ cell fraction compared with that in the 9 
CD45−ICAM-1+ cell fraction, the expression of phenotypic markers was 10 
examined. We found that CD45−ICAM-1+CD21/35+ cells expressed 11 
significantly greater levels of FDC-related genes (P < 0.001) compared with 12 
CD45−ICAM-1+ cells and two other stromal cell subsets (i.e., BECs and 13 
FRCs), indicating that the number of FDCs in the CD45−ICAM-1+CD21/35+ 14 
cell fraction was significantly higher than in the CD45−ICAM-1+ cell fraction 15 
(Fig. 1D). Moreover, CD45−ICAM-1+CD21/35+ cells showed a significantly 16 
 18 
lower expression of Stabilin2, Ccl19, and Pdgfrb, which are markers of BECs, 1 
FRCs, and splenic immature FDCs, respectively (Fig. 1E) (Krautler et al., 2 
2012; Link et al., 2007; Sørensen et al., 2012), indicating that the 3 
CD45−ICAM-1+CD21/35+ cell population was highly enriched with FDCs 4 
isolated from the spleen of naïve mice. 5 
 6 
3.3. Antigen retention by CD45−ICAM-1+CD21/35+ cells in vivo 7 
FDCs are capable of retaining opsonized antigen, which is required 8 
for germinal center maintenance and the establishment of long-term 9 
immune memory (Mandel et al., 1980; Victora and Nussenzweig, 2012). 10 
Therefore, we next examined the antigen retention of 11 
CD45−ICAM-1+CD21/35+ cells. Because FDCs retain intact antigen not only 12 
on the cell surface but also within recycling endosomal compartments for 13 
long-term storage (Heesters et al., 2013), mice were given FITC-labeled 14 
antigen to allow detection of the antigen on cell surfaces and in the cytosol of 15 
the stromal cells. Although the fluorescence signal was not detected in 16 
 19 
CD45−ICAM-1+ cells, BECs, or FRCs 7 days after antigen administration, a 1 
significant increase (P < 0.01) in fluorescence intensity was detected in 2 
CD45−ICAM-1+CD21/35+ cells isolated from mice administered the 3 
FITC-labeled antigen (Fig. 2A, B), indicating that CD45−ICAM-1+CD21/35+ 4 
cells retained the antigen for at least 7 days. Because FDCs are the only cells 5 
that retain intact antigens for long periods of time (Mandel et al., 1980), our 6 
study showed that the isolated CD45−ICAM-1+CD21/35+ cells exhibited not 7 
only the phenotypical but also the functional features of FDCs. 8 
 9 
3.4. Antigen presentation to cognate B cells by CD45−ICAM-1+CD21/35+ cells 10 
To investigate whether CD45−ICAM-1+CD21/35+ cells initiate the 11 
proliferation of cognate B cells, we isolated CD45−ICAM-1+ cells and 12 
CD45−ICAM-1+CD21/35+ cells from mice administered with NP-Ficoll and 13 
co-cultured the cells with CFSE-labeled QM B cells, which express 14 
NP-specific BCR (Fig. 3A). In a previous report, we showed that 15 
CD45−ICAM-1+ cells supported the survival naïve B cells (Usui et al., 2012). 16 
 20 
Consistent with this previous report, in the present study CD45−ICAM-1+ 1 
cells significantly enhanced B-cell survival and proliferation compared with 2 
negative control (P < 0.001; Fig. 3B–E). Furthermore, compared with 3 
CD45−ICAM-1+ cells, CD45−ICAM-1+CD21/35+ cells significantly prolonged 4 
QM B-cell survival (P < 0.001; Fig. 3B, C) and dramatically induced the 5 
proliferation of QM B cells (P < 0.001; Fig. 3D, E). To examine whether 6 
CD45−ICAM-1+CD21/35+ cells stimulate B cell proliferation in an 7 
antigen-dependent manner, CD45 − ICAM-1+CD21/35+ cells from mice 8 
administered NP-Ficoll were co-cultured with CFSE-labeled B cells derived 9 
from WT mice. In contrast to QM B cells, WT B cells showed little 10 
proliferation (Fig. 3 F, G), demonstrating that CD45−ICAM-1+CD21/35+ cells 11 
stimulated B cell proliferation in an antigen-dependent manner. Taken 12 
together, CD45−ICAM-1+CD21/35+ cells maintained their 13 
antigen-presentation abilities even after isolation via flow cytometry, 14 
suggesting that these cells are useful for the functional analysis of FDCs in 15 
vitro. 16 
 21 
 In conclusion, CD45−ICAM-1+CD21/35+ cells obtained with our 1 
improved protocol showed the following features typical of FDCs: 1) they 2 
were rare (0.07 % in stromal cell-enriched fractions of naïve spleen), 2) they 3 
had a comparable phenotype (FDC marker expression), and 3) they had 4 
comparable functions (antigen retention in vivo and antigen presentation to 5 
cognate B cells). Together, these data indicate that we were able to define 6 
CD45−ICAM-1+CD21/35+ cells phenotypically and functionally as a highly 7 
enriched FDC population. Our improved protocol therefore allows the 8 
isolation of a highly enriched preparation of viable FDCs without the need 9 
for treatments such as irradiation or immunization, which means that these 10 
cells are suitable for use in biochemical and genetic analyses of naïve FDCs. 11 
12 
 22 
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Table 1. Average number and percentage of cells in stromal cell subsets 1 
isolated from a single naïve mouse spleen. 2 
Percentages were calculated from the number of PI− gated cells from stromal 3 
cell-enriched fractions of naive mouse spleen after negative selection via 4 
biotinylated anti CD45, B220 and Ter119 followed by streptavidin magnetic 5 
beads. Data are representative of four experiments with three mice per 6 
replicate. 7 
8 
 30 
Fig. 1. Isolation and characterization of naïve CD45−ICAM-1+CD21/35+ cells. 1 
(A) Sorting strategy for the isolation of blood endothelial cells (BECs, 2 
CD45−ICAM-1+CD31+), fibroblastic reticular cells (FRCs, 3 
CD45−ICAM-1+PDPN+), CD45−ICAM-1+CD21/35+ cells, and CD45−ICAM-1+ 4 
cells from a stromal cell-enriched fraction from the spleen of naive mice. 5 
Numbers indicate the percentage of cells in each population.  6 
Representative plots of staining of B220 (B) and FDC-M2 (C). Open and 7 
shaded histograms indicate staining with indicated mAb and isotype control, 8 
respectively. Numbers indicate the mean fluorescence intensity (MFI). (D, 9 
E) The mRNA expression levels of FDC markers (B) and other stromal cell 10 
subset markers (C) were determined relative to those in CD45−ICAM-1+ cells. 11 
Statistical significance is shown compared with CD45−ICAM-1+ cells. (D, E) 12 
Data were pooled from three independent experiments. Error bars indicate 13 
SD. ***P < 0.001 14 
15 
 31 
Fig. 2. Antigen retention by CD45−ICAM-1+CD21/35+ cells isolated from 1 
antigen-administered mice 2 
Flow cytometric analysis of antigen retention by stromal cells isolated from 3 
mice intravenously administered 50 µg FITC-labeled TNP-Ficoll or 4 
phosphate-buffered saline (PBS) on day 7 after antigen administration. (A) 5 
Representative histograms (open histogram: antigen [Ag]-injected mice; 6 
shaded histogram, phosphate-buffered saline [PBS] control mice) showing 7 
retention of FITC-conjugated antigen by CD45−ICAM-1+ cells, blood 8 
endothelial cells (BECs, CD45−ICAM-1+CD31+), fibroblastic reticular cells 9 
(FRCs, CD45−ICAM-1+PDPN+), and CD45−ICAM-1+CD21/35+ cells. (B) 10 
Quantification data showing the mean fluorescence intensity (MFI) of each 11 
stromal cell subset isolated from the injected mice (n = 3) divided by that of 12 
PBS-administered control mice (n = 3). Data are pooled from three 13 
independent experiments. Error bars indicate SD. **P < 0.01. 14 
15 
 32 
Fig. 3. Antigen presentation to cognate B cells by isolated 1 
CD45−ICAM-1+CD21/35+ cells 2 
Schematic representation of the experimental protocol: CFSE-labeled naive 3 
QM B cells (B-G) and WT B cells (F, G) were co-cultured for 3 days in 96-well 4 
round-bottom plates with either CD45−ICAM-1+ cells or 5 
CD45−ICAM-1+CD21/35+ cells isolated from mice given 50 μg NP-Ficoll 6 
intravenously seven days previously. Cells were harvested and stained with 7 
anti-CD19 monoclonal antibodies, and CD19+ cells and CD19+PI− cells were 8 
examined by means of flow cytometry for survival (B, C) and proliferation 9 
(D-G), respectively. (B) Representative plots showing CD19+-gated cells. PI− 10 
cells were considered live B cells. (C) Bar graph showing the percentage of 11 
PI− cells in CD19+ gated (n = 3). (D-G) B-cell proliferation was analyzed by 12 
means of a CFSE-dilution assay. (D, F) Representative histograms showing 13 
CD19+PI−-gated cells co-cultured or not with CD45−ICAM-1+ cells or CD45−14 
ICAM-1+CD21/35+ cells. Numbers represent the frequency of divided B cells. 15 
(E, G) Bar graph indicating the percentage of divided B cells in the 16 
 33 
CD19+PI−-gated (n = 3). (B-G) Data are pooled from at least two independent 1 
experiments. Error bars indicate SD. ***P < 0.001. n.s., not significant. 2 
3 
 34 
Supplementary Fig. 1 CD21/35 expression after collagenase D treatment. 1 
Spleen cells were treated with high (33.3 mg/ml) or low (1mg/ml) 2 
concentration of collagenase D for 30 min at 37 ℃ and stained with 3 
anti-CD45 mAb. Representative plots of CD21/35 staining in CD45+ gated 4 
cells. Open and shaded histograms indicate staining with anti-CD21/35 mAb 5 
and isotype control, respectively. 6 
Table 1. 
 
 Dispase 
Cell number Percentage 
 Mean SD Mean SD 
CD45-ICAM-1+ cells + 276.88 26.0 61.00 4.65 
CD45-ICAM-1+CD31+ cells (BECs) + 269.96 25.7 59.47 4.48 
CD45-ICAM-1+PDPN+ cells (FRCs) + 1.77 0.4 0.39 0.06 
CD45-ICAM-1+CD21/35+ cells + 0.34 0.1 0.07 0.03 
CD45-ICAM-1+CD21/35+ cells - 0.12 0.04 0.07 0.02 
  (x 10e3 cells) (% of Live cells) 
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